Inventaire - your friends and communities are your best library

The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells.

published in: Neoplasia

date of publication: 2018-04-02

main subject: NF-κB

Cites articles 38

Date

Title

Authors

2017-01-09

Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3.

Antons Martincuks, Gerhard Müller-Newen
2016-05-17

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Luca Gianni, Justin M. Balko
2015-07-13

Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity

Luca Pinello
2015-02-12

Triple-negative breast cancer in African-American women: disparities versus biology

Victoria L Seewaldt, Ruth M O'Regan
2015-12-23

Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome

Jaehyuk Choi
2014-01-28

STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes

Nicolai Juul Birkbak, Vida Vafaizadeh, Mark P. Boldin
2013-05-28

STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6

Luca Pinello
2013-03-24

Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer
2011-08-05

Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
2011-06-01

A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation
2011-07-01

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

Mithat Gönen, William C Hahn, David E Root, Kornelia Polyak
2010-05-01

Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors

Denzil Bernard, Shaomeng Wang
2010-05-28

Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells

John R Bradley
2010-01-01

The regulatory logic of the NF-kappaB signaling system
2010-02

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

Michael Karin
2009-10-01

The NF-kappaB family of transcription factors and its regulation
2009-12-01

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors
2009-11-06

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

Florian Greten
2009-08-17

Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells

Carine Van Lint
2009-06-02

Reciprocal effects of STAT5 and STAT3 in breast cancer

Sabina Signoretti
2009

Regulation and function of NF-kappaB transcription factors in the immune system
2008-02-01

Shared principles in NF-kappaB signaling

Matthew S Hayden, Sankar Ghosh
2008-02-04

NF-kappa B genes have a major role in inflammatory breast cancer

Rosette Lidereau, Ivan Bieche, Sophie Vacher
2006-04-01

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

Alexander Eggermont
2006-05-01

Shaping alternative NF-kappaB-dependent gene expression programs: new clues to specificity

Gioacchino Natoli, Francesca De Santa
2005-09-30

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Eric Lander, Jill P. Mesirov, Sayan Mukherjee, Todd Golub, Pablo Tamayo, Benjamin L. Ebert, Scott L Pomeroy
2005-06-01

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

Massimo Loda
2005-04-27

NF-kB in development and progression of human cancer

Xavier Matias-Guiu Guia
2005-03-21

A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
2005-02-01

Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo

Masakazu Toi
2004-10-20

Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification
2003-07

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Eric Lander, Mark Joseph Daly, David Altshuler, Jill P. Mesirov, Pablo Tamayo, Nick Patterson, Per Eriksson

Article - wd:Q55278638

Welcome to Inventaire

the library of your friends and communities

learn more